Fin ct 13

jop.0820501.pdf

Home >English homework help >Article writing homework help >Fin ct 13

From the Editor’s Desk

Strengths, Weaknesses, Opportunities, and Threats

The SWOT analysis, whereby leaders assess an organization’s strengths, weaknesses, opportunities, and threats, is a useful and time-tested leadership tool. You may have encountered it in strategic planning exercises in hospitals, health care systems, or other business settings. The SWOT analysis is a structured, systematic way of thinking about, and exploring areas for business development, for resource deployment (including physical, personal, and intellectual resources), and areas of vulnerability needing improvement or development. JOP has featured a variety of practice, process, and quality improvement tools. Perhaps it is time to do a SWOT analysis on our discipline.

A strength of the practice of oncology that first comes to mind is its scientific and evidence basis. Almost all of our potentially curative, supportive, and palliative treatments are scientifically derived, with validated clinical trial evidence to support them. This allows the treatments we offer to be evidence based and quality focused. The motivation, caring, and compassion of our colleagues (very few of us are drawn to oncology who do not have care of the sick and vulnerable cancer patient as our primary life mission) is also our strength. Another strength of our current service model is team-based practice. Oncology patients receive care from teams with highly developed areas of expertise. These teams include our oncology nurses, office managers and staff, chemotherapy nurses in offices and cancer treatment centers, as well as a highly skilled and dedicated array of other physicians—surgeons, radiation oncologists, pathologists, and diagnostic radiologists and their respective teams, to name a few. When necessary, we also coordinate hospice and palliative care services for our patients, as well as dietary, social work, and other support services. This complex, evidence-based, caring team approach is the strength of our discipline.

As I see it, we have two main weaknesses. The most obvious is that despite the decreases in cancer-related mortality we have in the United States, we don’t cure everybody, or even everybody whom we should cure. The second weakness I see is our inefficient allocation of our limited personal time and energy with the patient—the 15, 20, or even 90 minutes that we spend with patients is never enough to meet their needs or fully coordinate the complexities of care. Related to the time problem is a reimbursement problem. Many commentators forecast the bankruptcy of our current payment system as increasing demands for services clash with the limited resources available for reimbursement.

Identification of opportunities is often informed by the analysis of weaknesses. Because we don’t cure everybody, there are still problems that await repair, including resolving access-to-care barriers; development of clinical trials to test new agents and combinations of agents; and new treatment strategies that can be designed, executed, and reported. The coming changes in health care reimbursement mechanisms will create opportunities to add value to and be compensated for the quality and efficiency that are so valued by second- (eg, the patient or family) and third-party payers. The forecasted shortage of trained oncologists is an opportunity to redesign care-delivery models and perhaps re-establish what economists refer to as “pricing power.”

Threats to our professional efforts may come from these same second- and third-party payers, who will continue to press their desire to pay less for the services we are currently organized to deliver. The aging of the oncology workforce and the aging of the population threaten to overwhelm our current oncology care system. A potential “threat,” albeit one with a happy outcome, is that cancer will be cured with a simple measure or measures, and we will have little to do. The basic and clinical scientists with whom I speak tell me that this is unlikely, but let us work toward making this happy “threat” be realized.

A SWOT analysis; there you have it.

DOI: 10.1200/JOP.0820501

Douglas W. Blayney, MD

M A R C H 2 0 0 8 • j o p . a s c o p u b s . o r g 5 3Copyright © 2008 by American Society of Clinical Oncology Downloaded from ascopubs.org by 176.18.149.233 on November 27, 2018 from 176.018.149.233

From the Editor’s Desk

Strengths, Weaknesses, Opportunities, and Threats Douglas W. Blayney, MD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53

Commentary

Communication at the End of Life Lidia Schapira, MD. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54

Original Research

Targeting Lymph Node Retrieval and Assessment in Stage II Colon Cancer: A Quality Outcome Community-Based Cancer Center Study

Thomas Grote, MD, Amy H. Hughes, Cathy C. Rimmer, MDiv, Dale A. Less, Amy P. Abernathy, MD, and the Multidisciplinary Gastrointestinal Tumor Board, Derrick L. Davis Forsyth Regional Cancer Center . . . . . . . . . 55

Effect of Pretreatment Distress on Daily Fatigue After Chemotherapy for Breast Cancer

Sara C. Higgins, PhD, Guy H. Montgomery, PhD, George Raptis, MD, and Dana H. Bovbjerg, PhD . . . . . . . . 59

Business of the Business

Legal Corner Genetic Testing for Cancer: Legal, Ethical, and Practical Issues for the Practicing Oncologist

Elizabeth Goss, JD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64

Practical Tips The CMS Physician Quality Reporting Initiative . . . . . . . . . . 66 Making the Move to a Multispecialty Oncology Practice. . . 68

Profiles in Success

An Interview With Peter G. Ellis, MD . . . . . . . . . . . . . . . . . . . . 71

Cover Story

Hospital-Physician Relationships: Taking a Proactive Approach to Building Mutually Successful Relationships . . 72

The Voice of ASCO

ASCO’s Clinical Practice Committee Cancer Care Is Costly

Therese M. Mulvey, MD. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 77

Clinical Research

The Southwest Oncology Group: New Processes to Coordinate Increasingly Complex Clinical Trials . . . . . . . . . . 78 Making Research Dollars Stretch for Community Practices . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 81 Ensuring Patient Safety and Scientific Credibility in Clinical Trials . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 83

For Your Patients

PLWC Resources What’s New at PLWC.org . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85

Patient Advocate Corner C3: Colorectal Cancer Coalition — Pushing for Better Research, Faster

Carlea Bauman . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 86

Training and Development

Focus on Staff Supportive Care Services Address Many Patient Needs. . . . . 87

Strategies for Career Success

Practice Efficiency and Practice Quality: Flip Sides of the Same Coin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 90

Technology and Innovation

Apheresis in the Office Setting . . . . . . . . . . . . . . . . . . . . . . . . . . . 94 Genetic Counseling: An Indispensable Step in the Genetic Testing Process . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 96

Current Clinical Issues

Making the Decision to Not Attempt Resuscitation Joanna Cain, MD, Courtney Storm, JD, MBE, and Ian Olver, MD, PhD. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99

Reproductive Health Issues in Women With Cancer . . . . . 101

Journal of Oncology

Practice Contents

V o l u m e 4 I s s u e 2 , M a r c h 2 0 0 8

Journal of Oncology Practice (ISSN 1554-7477) is published 6 times a year (January, March, May, July, September, November), by American Society of Clinical Oncology, 1900 Duke St, Suite 200, Alexandria, VA 22314. Periodicals postage pending at Alexandria, VA, and at additional mailing offices. Publication Mail Agreement Number pending. Editorial correspondence should be addressed to Douglas W. Blayney, MD, Journal of Oncology Practice, 330 John Carlyle St, Suite 300, Alexandria, VA 22314; telephone, 703-797-1900; fax, 703-684-8720; e-mail, [email protected]. © American Society of Clinical Oncology

POSTMASTER: Send change of address to Journal of Oncology Practice, American Society of Clinical Oncology, 1900 Duke St, Suite 200, Alexandria, VA 22314. Nonmembers send change of address to Journal of Oncology Practice, Customer Service, 330 John Carlyle St, Suite 300, Alexandria, VA 22314.

Annual subscription rates (effective through August 31, 2008): United States and possessions: ASCO active-allied, $50; ASCO affiliate, $50; nonmember individual US, $125; nonmember individual international, $145; in-training US, $65; in-training international, $75; institutional US, $200; institutional international, $250; single issue US, $25; single issue international, $35.

To receive in-training rate, orders must be accompanied by name of affiliated institution, date of term, and the signature of program/residency coordinator on institution letterhead. Orders will be billed at individual rate until proof of status is received. Current prices are in effect for back volumes and back issues. Back issues sold in conjunction with a subscription rate on a prorated basis. Subscriptions are accepted on a calendar-year basis. Prices are subject to change without notice. Single issues, both current and back, exist in limited quantities, and are offered for sale subject to availability.